Inhibition of the Receptor for Advanced Glycation End-Products in Acute Respiratory Distress Syndrome: A Randomised Laboratory Trial in Piglets

Production and application of HMGB1 derived recombinant RAGE-antagonist peptide for anti-inflammatory therapy in acute lung injury

(2018) Seonyeong Lee et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Inhibition of RAGE Attenuates Cigarette Smoke-Induced Lung Epithelial Cell Damage via RAGE-Mediated Nrf2/DAMP Signaling

(2018) Hanbyeol Lee et al.   Frontiers in Pharmacology

Plasma sRAGE is independently associated with increased mortality in ARDS: a meta-analysis of individual patient data

(2018) Matthieu Jabaudon et al.   INTENSIVE CARE MEDICINE

Acute Respiratory Distress Syndrome

(2017) B. Taylor Thompson et al.   NEW ENGLAND JOURNAL OF MEDICINE

RAGE inhibition reduces acute lung injury in mice

(2017) Raiko Blondonnet et al.   Scientific Reports

Elevated Plasma Levels of sRAGE Are Associated With Nonfocal CT-Based Lung Imaging in Patients With ARDS

(2016) Segolene Mrozek et al.   CHEST

Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries

(2016) Giacomo Bellani et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Small Molecule Inhibition of Ligand-Stimulated RAGE-DIAPH1 Signal Transduction

(2016) Michaele B. Manigrasso et al.   Scientific Reports

Soluble Receptor for Advanced Glycation End-Products Predicts Impaired Alveolar Fluid Clearance in Acute Respiratory Distress Syndrome

(2015) Matthieu Jabaudon et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Receptor for Advanced Glycation End-Products Regulates Lung Fluid Balance via Protein Kinase C–gp91phoxSignaling to Epithelial Sodium Channels

(2015) Charles A. Downs et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Extravascular lung water in critical care: recent advances and clinical applications

(2015) Mathieu Jozwiak et al.   Annals of Intensive Care

Soluble Forms and Ligands of the Receptor for Advanced Glycation End-Products in Patients with Acute Respiratory Distress Syndrome: An Observational Prospective Study

(2015) Matthieu Jabaudon et al.   PLoS One

Resolution of Pulmonary Edema. Thirty Years of Progress

(2014) Michael A. Matthay   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Effect of TTP488 in patients with mild to moderate Alzheimer’s disease

(2014) Aaron H Burstein et al.   BMC Neurology

Clinical trial of an inhibitor of RAGE-A  interactions in Alzheimer disease

(2014) D. Galasko et al.   NEUROLOGY

Cellular signalling of the receptor for advanced glycation end products (RAGE)

(2013) Jianling Xie et al.   CELLULAR SIGNALLING

Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products

(2013) Giancarlo Aldini et al.   FREE RADICAL RESEARCH

Effects of Positive End-expiratory Pressure Titration and Recruitment Maneuver on Lung Inflammation and Hyperinflation in Experimental Acid Aspiration–induced Lung Injury

(2012) Aline M. Ambrosio et al.   ANESTHESIOLOGY

S100P-Derived RAGE Antagonistic Peptide Reduces Tumor Growth and Metastasis

(2012) T. Arumugam et al.   CLINICAL CANCER RESEARCH

Potential Clinical Utility of Advanced Glycation End Product Cross-Link Breakers in Age- and Diabetes-Associated Disorders

(2012) Sho-ichi Yamagishi   REJUVENATION RESEARCH

An Official American Thoracic Society Workshop Report: Features and Measurements of Experimental Acute Lung Injury in Animals

(2011) Gustavo Matute-Bello et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

HMGB1 Is a Therapeutic Target for Sterile Inflammation and Infection

(2011) Ulf Andersson et al.   Annual Review of Immunology

Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients*

(2011) Matthieu Jabaudon et al.   CRITICAL CARE MEDICINE

Lack of the Receptor for Advanced Glycation End-Products Attenuates E. coli Pneumonia in Mice

(2011) Lasse Ramsgaard et al.   PLoS One

A Monoclonal Antibody Against RAGE Alters Gene Expression and is Protective in Experimental Models of Sepsis and Pneumococcal Pneumonia

(2011) Eirini Christaki et al.   SHOCK

The RAGE axis in systemic inflammation, acute lung injury and myocardial dysfunction: an important therapeutic target?

(2010) Benedict C. Creagh-Brown et al.   INTENSIVE CARE MEDICINE

Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research

(2010) Carol Kilkenny et al.   PLOS BIOLOGY

The Receptor for Advanced Glycation End Products Impairs Host Defense in Pneumococcal Pneumonia

(2009) M. A. D. van Zoelen et al.   JOURNAL OF IMMUNOLOGY

Receptor for Advanced Glycation End Products Facilitates Host Defense duringEscherichia coli–Induced Abdominal Sepsis in Mice

(2009) Marieke A. D. van Zoelen et al.   JOURNAL OF INFECTIOUS DISEASES

Hemodynamic effects of PEEP in a porcine model of HCl-induced mild acute lung injury

(2008) C. K. MARUMO et al.   ACTA ANAESTHESIOLOGICA SCANDINAVICA

Role of Soluble Receptor for Advanced Glycation End Products on Endotoxin-induced Lung Injury

(2008) Haiying Zhang et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Elevated Levels of the Receptor for Advanced Glycation End Products, a Marker of Alveolar Epithelial Type I Cell Injury, Predict Impaired Alveolar Fluid Clearance in Isolated Perfused Human Lungs

(2008) Raphael Briot et al.   CHEST

Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury

(2008) C S Calfee et al.   THORAX